316 related articles for article (PubMed ID: 28453946)
1. A Dermatologist's Approach to Genitourinary Syndrome of Menopause.
Hum M; Dytoc M
J Cutan Med Surg; 2017; 21(5):418-424. PubMed ID: 28453946
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and Treatment of Genitourinary Syndrome of Menopause.
Hodges AL; Holland AC; Dehn B; Pace DT
Nurs Womens Health; 2018 Oct; 22(5):423-430. PubMed ID: 30170002
[TBL] [Abstract][Full Text] [Related]
3. Genitourinary Syndrome of Menopause: Management Strategies for the Clinician.
Faubion SS; Sood R; Kapoor E
Mayo Clin Proc; 2017 Dec; 92(12):1842-1849. PubMed ID: 29202940
[TBL] [Abstract][Full Text] [Related]
4. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
[TBL] [Abstract][Full Text] [Related]
5. Atrophic vaginitis.
Stika CS
Dermatol Ther; 2010; 23(5):514-22. PubMed ID: 20868405
[TBL] [Abstract][Full Text] [Related]
6. Vaginal estrogens for the treatment of dyspareunia.
Krychman ML
J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
[TBL] [Abstract][Full Text] [Related]
7. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management.
Gandhi J; Chen A; Dagur G; Suh Y; Smith N; Cali B; Khan SA
Am J Obstet Gynecol; 2016 Dec; 215(6):704-711. PubMed ID: 27472999
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis.
Safary M; Hakimi S; Mobaraki-Asl N; Amiri P; Tvassoli H; Delazar A
Curr Drug Deliv; 2020; 17(9):815-822. PubMed ID: 32640956
[TBL] [Abstract][Full Text] [Related]
9. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
[TBL] [Abstract][Full Text] [Related]
10. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
The NAMS 2020 GSM Position Statement Editorial Panel
Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
[TBL] [Abstract][Full Text] [Related]
11. Resistance and barriers to local estrogen therapy in women with atrophic vaginitis.
Kingsberg SA; Krychman ML
J Sex Med; 2013 Jun; 10(6):1567-74. PubMed ID: 23534861
[TBL] [Abstract][Full Text] [Related]
12. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
Portman DJ; Gass ML;
Maturitas; 2014 Nov; 79(3):349-54. PubMed ID: 25179577
[TBL] [Abstract][Full Text] [Related]
13. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
Portman DJ; Gass ML;
J Sex Med; 2014 Dec; 11(12):2865-72. PubMed ID: 25155380
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of a plant-based, multi-component cream (Ginetrox®) in vulvovaginal disorders of the genitourinary syndrome during menopause.
Marrai R; Lissi G; Togni S; Maramaldi G; Barbara M; Giacomelli L
Minerva Ginecol; 2017 Jun; 69(3):245-249. PubMed ID: 28420227
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy.
Pérez-López FR; Vieira-Baptista P; Phillips N; Cohen-Sacher B; Fialho SCAV; Stockdale CK
Gynecol Endocrinol; 2021 Aug; 37(8):740-745. PubMed ID: 34036849
[TBL] [Abstract][Full Text] [Related]
16. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society.
Portman DJ; Gass ML;
Climacteric; 2014 Oct; 17(5):557-63. PubMed ID: 25153131
[TBL] [Abstract][Full Text] [Related]
17. Different local estrogen therapies for a tailored approach to GSM.
Nappi RE; Tiranini L; Martini E; Bosoni D; Cassani C; Cucinella L
Climacteric; 2023 Aug; 26(4):361-366. PubMed ID: 37318030
[TBL] [Abstract][Full Text] [Related]
18. Vaginitis.
Hainer BL; Gibson MV
Am Fam Physician; 2011 Apr; 83(7):807-15. PubMed ID: 21524046
[TBL] [Abstract][Full Text] [Related]
19. The Genitourinary Syndrome of Menopause: An Overview of the Recent Data.
Angelou K; Grigoriadis T; Diakosavvas M; Zacharakis D; Athanasiou S
Cureus; 2020 Apr; 12(4):e7586. PubMed ID: 32399320
[TBL] [Abstract][Full Text] [Related]
20. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
Wallace SL; St Martin B; Lee K; Sokol ER
Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]